Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VIIa

Klinische Padiatrie

Volumn 217, Issue 6, 2005, Pages 365-370

  Hennewig, Ulrike ^a   Laws, H J ^a   Eisert, S ^a   Gobel U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Glanzmann Thrombasthenia; Indication for use; Recombinant factor VIIa

Indexed keywords

ANTIFIBRINOLYTIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ARTICLE; BLEEDING; CAUTERIZATION; CLINICAL ARTICLE; DENTAL SURGERY; DISEASE SEVERITY; DRUG EFFICACY; ELBOW; GLANZMANN DISEASE; HUMAN; MEDICAL RECORD; MUCOSAL BLEEDING; RECURRENT DISEASE; THROMBOCYTE TRANSFUSION; TOOTH EXTRACTION; TREATMENT OUTCOME;

ADOLESCENT; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FACTOR VIIA; FEMALE; HEMARTHROSIS; HEMORRHAGE; HUMANS; MALE; ORAL HEMORRHAGE; PLATELET TRANSFUSION; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; THROMBASTHENIA; TOOTH EXTRACTION;

EID: 28544445198     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872523     Document Type: Article

References (13)

1. Almeida A, Khair K, Hann I, Liesner R. The use of recombinant factor - VIIa in children with inherited platelet function disorders. Br J Hematol 2003; 121: 477-481
2. Boval B, Belucci S, Boyer-Neumann C, d'Oiron R, Ciraru-Vigneron N, Audibert F, Wautier JL. Glanzmann thrombasthenia and pregnancy: clinical observations and management of four affected women (abstract). Thromb Haemost 2001; (Suppl): P1154
3. Caglar K, Cetinkaya A, Aytac S, Gumruk F, Gurgey A. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Pediatr Hematol Oncol 2003; 20: 435-438
4. Chuansumskrit A, Suwannuraks M, Sri-Udomporn N, Pongtanakul B, Worapongpaiboon S. Recombinant activated VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. Blood Coagul Fibrinolysis 2003; 14: 187-190
5. Creutzig U, Jurgens H, Herold R, Gobel U, Henze G. Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology. Klin Padiatr 2004; 216: 379-383
6. Fressinaud E, Sigaud-Fiks M, Le Boterff C. Use of recombinant factor - VIIa (Novo Seven) for dental extraction in a patient affected by platelet - type (pseudo-) von Willebrandt disease. Hemophilia 1998; 4: 299
7. Graf N, Gobel U. Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials. Klin Padiatr 2004; 216: 129-131
8. Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 1998; 80: 323
9. Poon MC, Demers C, Jobin F, Wu JWY. Recombinant Factor VIIa is Effective for Bleeding and Surgery in Patients with Glanzmann Thromboasthenia. Blood 1999; 94: 3951-3953
10. Poon MC, D'Oiron R, von Depka M, Khair K, Négrier C, Karafoulidou A, Huth-Kuehne A, Morfini M. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's throbasthenia: results of an international survey. J Thromb Hemost 2004; 2: 1096-1103
11. Shapiro AD, Gilchrist G, Hoots WK, Cooper HA, Gastineau DA. Prospective randomised trial of two doses of rFVIIa (Novo Seven) in hemophilia patients with inhibitor undergoing surgery. Thromb Haemost 1998; 80: 773-778
12. Tengborn L, Petruson B. A patient with Glanzmann thromboasthenia and epistaxis successfully treated with recombinant factor VIIa (letter). Thromb Haemost 1996; 75: 981
13. www.gth-online.org: pediatric section, current studies, thrombocytopathy.